does ambetter cover tirzepatide TrimRX Ambetter Drug Rehab Coverage |

Its Phase 3 weight-loss figures (in the low-to-mid 20% range) and its late-2025 FDA filing belong to the combination product, not to standalone cagrilintide, which remains at the Phase 2 stage with a peer-reviewed monotherapy result of about 10.8% at 26 weeks

Most gastroenterologists recommend pausing GLP-1 therapy during active infection (typically 714 days of antibiotics and bowel rest) and waiting 46 weeks after resolution before restarting

This combination of mechanisms makes Mounjaro more effective at promoting weight loss compared to medications that target just one of these pathways

We would not accept that for any other deadly diseaseThis is observational evidence

If you need to discontinue, talk to your provider about a plan to maintain your results through diet and lifestyle changes

Small E, Cronquist A